The 103D6 monoclonal antibody is a mouse IgG2c inhibitor targeting mouse osteopontin (SPP1). It is a valuable tool for investigating the role of SPP1 in bone metabolism, cancer progression, and immune responses in both cell-based assays and animal models.
Target-Kategorie:
Integrin
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten